The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?

The new realities of biotech trial supply: Key strategies to navigate

Today’s clinical supply landscape is different than in years past—watch this webinar to discover strategies for navigating geographic shifts, device complexity, and trade pressure.

Clinical trial activity continues to move out of parts of Eastern Europe and into Latin America and across the Asia-Pacific region, often for access, cost, and enrollment reasons. Meanwhile, ongoing trade friction and tariff dynamics are influencing where labeling, distribution, and packaging of products take place.

These shifts demand more than incremental adjustments—they necessitate strategic change.

What you’ll learn about biotech trial supply strategy in a changing global landscape

This on-demand webinar, originally presented alongside Pharma Ignite, examines what that looks like in practice while maintaining momentum—from structuring supply networks that can adapt as geographies shift, to building stronger alignment across labeling, packaging, and distribution so programs stay on track despite changing conditions.

Watch this webinar to discover:

  • Why end-to-end visibility across labeling, packaging, and logistics is critical
  • How geographic shifts and trade dynamics are influencing supply strategies
  • The value of integrated, end-to-end networks in maintaining timeline control
  • How experienced teams and advanced technology can help sustain speed
Speaker
Kirk Bray
Senior Manager, West Coast Biotech
Clinical Trials, Pharma Services
Thermo Fisher Scientific